MARKET

IVA

IVA

Inventiva S.A.
NASDAQ
3.570
+0.060
+1.71%
Opening 15:16 05/13 EDT
OPEN
3.520
PREV CLOSE
3.510
HIGH
3.601
LOW
3.520
VOLUME
10.07K
TURNOVER
--
52 WEEK HIGH
4.050
52 WEEK LOW
1.530
MARKET CAP
341.51M
P/E (TTM)
-1.1134
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IVA last week (0505-0509)?
Weekly Report · 1d ago
Inventiva Secures €115.6 Million Through T2 Subscription Agreement
TipRanks · 05/05 21:48
Weekly Report: what happened at IVA last week (0428-0502)?
Weekly Report · 05/05 10:41
Inventiva Secures €116M Second Tranche From €348M Financing To Advance Lanifibranor In MASH
Benzinga · 05/05 07:13
INVENTIVA SECURES THE €116 MILLION SECOND TRANCHE OF ITS STRUCTURED FINANCING OF UP TO €348 MILLION
Reuters · 05/05 06:30
Inventiva Announces General Meeting to Discuss Key Financial and Strategic Decisions
TipRanks · 05/02 20:27
Inventiva Announces Preparatory Documents for May 2025 General Meeting
TipRanks · 04/30 21:07
Inventiva Announces Voting Rights and Share Capital Update as of April 2025
TipRanks · 04/30 21:07
More
About IVA
More
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.
Recently
Symbol
Price
%Change
    XHG
  • 2.760
  • +23.21%

Webull offers Inventiva SA stock information, including NASDAQ: IVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVA stock methods without spending real money on the virtual paper trading platform.